How Common Brain Tumours Are, and What a Meningioma Is

The scan was for a stiff neck after a minor car accident. Nothing dramatic, the radiologist said, but there was a small, round shadow pressing gently against the surface of the brain, and it had a name that sounded like a diagnosis from a medical drama: meningioma. By the time she reached the parking lot she had typed the word into her phone twice, misspelled it once, and read three articles that agreed on almost nothing.

That scene plays out thousands of times a year. Better imaging means more people learn they have a brain tumor before it ever causes a symptom, and the gap between how frightening the words sound and what the evidence shows is unusually wide.

This article closes that gap. It looks honestly at how often brain tumors occur, why the phrase covers such different conditions, and what a meningioma actually is, using registry data and mainstream clinical sources rather than the loudest headline.

How common is a brain tumor, really?

Ask a room full of adults to guess their odds of a brain tumor and most will aim high. Brain tumors hold an outsized place in the imagination, partly because the organ they affect is the one doing the imagining. Registry data are calmer.

The National Cancer Institute’s SEER program, which tracks cancer across the United States, records about 6 new malignant brain and other nervous system cancers per 100,000 people each year. That is roughly 1.2 percent of all new cancer diagnoses. Put another way, the lifetime risk of a malignant brain or nervous system cancer is about 0.6 percent, close to 1 in 170 people. Each year that translates into roughly 25,000 new diagnoses and 18,000 to 19,000 deaths nationally.

Those figures count only tumors classed as malignant. Non-cancerous brain tumors are recorded separately, and they are found more often than cancerous ones, with meningioma leading the list. Johns Hopkins Medicine describes meningioma as the most common primary brain tumor, accounting for about 30 percent of all brain tumors.

So the fuller answer has two parts. Cancer that begins in the brain is genuinely uncommon, rarer than colon, breast, lung or prostate cancer by a wide margin. Brain tumors of all kinds, including slow-growing benign ones, are found more often than most people assume, and a good share of them are discovered before they cause any trouble at all. Both facts matter, and neither should be quoted without the other.

Why 'brain tumor' is a broader term than most people think

A brain tumor is any abnormal mass of cells growing inside the skull. That definition sweeps in more than a hundred different tumor types, and the differences between them are larger than the similarities. Two people who each say “I have a brain tumor” may face situations that share almost nothing except the word.

The first fork is where the tumor started. Primary brain tumors arise from brain tissue itself or from the structures around it: the membranes, the nerves, the pituitary gland. Secondary brain tumors, also called brain metastases, are cancers that began somewhere else, most often the lung, breast, kidney, bowel or skin, and traveled to the brain through the bloodstream. Mayo Clinic notes that secondary brain tumors are far more common than primary ones, which is why a large share of brain tumors seen in hospitals belong to people who already have a cancer diagnosis elsewhere.

The second fork is cell type. Gliomas grow from the glial cells that support neurons. Meningiomas grow from the meninges, the layered covering of the brain and spinal cord. Pituitary adenomas grow from the hormone-producing gland at the base of the brain. Acoustic neuromas grow along the hearing nerve. Each behaves according to its own biology, which is why headlines about one tumor type rarely apply to another.

Statistics about “brain tumors” almost always mean primary tumors, and often only the malignant subset. Whenever a number sounds alarming or reassuring, the first question worth asking is which tumors it counted.

Is every brain tumor cancer? What the grades mean

No. The NHS grades brain tumors from 1 to 4 according to how quickly they are likely to grow and how abnormal their cells look under the microscope. Grades 1 and 2 are low grade and are generally described as non-cancerous. Grades 3 and 4 are high grade and are cancerous.

Grade	Usual description	Typical behavior
1	Low grade, non-cancerous	Slow growing, cells look close to normal, often does not return after removal
2	Low grade, non-cancerous	Slow growing but more likely to come back, may change grade over time
3	High grade, cancerous	Actively growing, cells look clearly abnormal
4	High grade, cancerous	Fast growing, spreads into nearby brain tissue

The word “benign” deserves scrutiny in the brain, though. A benign tumor in the skin or thyroid can often be ignored. Inside a rigid skull, even a slow-growing mass occupies space that the brain cannot give up, and the location decides how much that matters. A grade 1 tumor beside the optic nerve can threaten sight; a similar tumor under the top of the skull may sit quietly for decades. Doctors weigh grade and position together, never one alone.

Nor is grade fixed forever. Some low-grade tumors change over the years, which is one reason follow-up scans are part of care even after a reassuring first result.

Who gets brain tumors, and what actually raises the risk?

Brain tumors can appear at any age, including in childhood, but SEER data show the median age at diagnosis for malignant brain and nervous system cancer is 61. Risk climbs through the sixties and seventies, in line with most cancers. Children are a notable exception to the general rarity: brain tumors are among the most common solid tumors in childhood, although they remain rare in absolute terms.

The list of confirmed causes is short. The NHS and Mayo Clinic point to two well-established factors. The first is prior exposure of the head to ionizing radiation, usually radiotherapy given years earlier for another condition. The second is a small group of inherited syndromes, such as neurofibromatosis, tuberous sclerosis and Li-Fraumeni syndrome, that carry gene changes affecting cell growth. A family history of brain tumors slightly raises risk, although most people diagnosed have no affected relative at all.

What about the suspects that fill social media? Cell phones have been studied intensively for two decades. Mayo Clinic summarizes the current position plainly: research has not shown a consistent link between phone use and brain tumors, and the evidence remains under review as usage patterns change. Head injuries, hair dye, artificial sweeteners and power lines have similarly failed to show a reliable connection in mainstream studies.

The honest conclusion is uncomfortable for anyone who wants a reason. Most brain tumors arise from random changes in cells, with no lifestyle choice to point to. That is not a failure of research; it is what the research found.

What is a meningioma?

Wrap the brain in three thin layers of tissue and you have the meninges. The tough outer layer is the dura, the middle is the arachnoid, and the delicate inner layer is the pia. A meningioma grows from cells in the arachnoid layer, which is why it sits on the surface of the brain rather than inside it. Cleveland Clinic and Mayo Clinic both describe it this way: a tumor that forms in the membranes surrounding the brain and spinal cord, pressing inward as it grows rather than infiltrating the tissue beneath.

That distinction shapes almost everything about the condition. A meningioma tends to have a defined edge. It often has a broad base attached to the dura, sometimes with a small “tail” visible on scans. Surgeons can frequently see where it ends and normal tissue begins, which is not true of many tumors arising within the brain itself.

Growth is usually slow, measured in millimeters per year rather than weeks. Many meningiomas take years to reach a size that causes symptoms, and a substantial number never do. That slowness explains why so many are found incidentally, during a scan for headaches, dizziness, a head injury or a sinus problem, and why the finding often arrives with the strange sentence, “You have a brain tumor, and it is probably nothing to worry about right now.”

Meningiomas can also form along the spinal cord, where the same membranes continue downward, though the brain is by far the more common site.

How common are meningiomas, and who is most likely to have one?

Meningioma is the most common primary brain tumor. Johns Hopkins Medicine puts its share at about 30 percent of all brain tumors, which means that when a scan shows a tumor arising within the skull, roughly one in three turns out to be this type. Because most are non-cancerous, they sit largely outside the malignant statistics quoted in the first section, and adding them changes the picture of how common brain tumors are considerably.

Two patterns stand out in who develops them. Age is the first. Meningiomas are uncommon in children and become steadily more frequent through middle age and beyond, with most diagnoses made in people over 40. Sex is the second. Johns Hopkins reports that women are affected roughly twice as often as men, a ratio consistent across many populations. Researchers suspect hormones play a part, since many meningiomas carry receptors for progesterone and some grow faster during pregnancy, but the mechanism is not fully settled and the evidence is best described as suggestive rather than proven.

Beyond age and sex, the recognized risk factors echo those for brain tumors generally: earlier radiation to the head and neurofibromatosis type 2, an inherited condition in which multiple meningiomas can appear. Mayo Clinic also lists higher body weight among factors associated with meningioma in population studies, an association that remains under investigation.

Autopsy studies over the decades have repeatedly found small, unsuspected meningiomas in people who died of unrelated causes, a quiet reminder that a fair number of these tumors are carried through life without ever announcing themselves.

Meningioma grades: what 'benign' does and doesn't mean

Meningiomas are graded on the same 1-to-3 framework used for the membranes’ tumors specifically, and the distribution is heavily weighted toward the gentle end. Johns Hopkins notes that most meningiomas, about 80 to 90 percent, are grade 1, meaning slow growing, non-cancerous and unlikely to return once completely removed.

Grade 2 meningiomas, called atypical, make up most of the remainder. Their cells divide more actively, they are more likely to regrow after surgery, and they are followed more closely. Grade 3 meningiomas, known as anaplastic or malignant, are uncommon. They grow quickly, can invade brain tissue and may, very rarely, spread elsewhere in the body.

Grading is done by a pathologist looking at tissue, so it requires surgery or a biopsy. A meningioma that is simply being watched on scans has not been formally graded; its behavior on repeat imaging stands in for the microscope.

Here the word benign earns its footnote. Grade tells you how the cells behave. Location tells you what that behavior costs. A grade 1 meningioma at the base of the skull, wrapped around arteries and cranial nerves, can be far harder to manage than a grade 2 tumor sitting conveniently under the top of the skull. Clinicians describe meningiomas by both features together, for instance “a grade 1 convexity meningioma” or “a skull-base meningioma near the optic nerve,” and the second half of that phrase often matters more than the first.

People sometimes hear “benign” and feel dismissed, or hear “tumor” and feel doomed. The accurate reading sits between: a real condition, usually slow, that deserves attention proportionate to its size, grade and position.

What are the warning signs of a brain tumor?

The NHS lists six symptom groups that most often lead to a brain tumor diagnosis, and it is worth knowing them precisely rather than vaguely.

• Headaches, particularly ones that are new, steadily worsening, worse in the morning or on lying down, or that wake you from sleep
• Seizures, whether a full convulsion or briefer episodes of twitching, staring or altered awareness
• Persistent nausea, vomiting and drowsiness without another explanation
• Mental or behavioral changes, such as memory problems, confusion or a shift in personality noticed by others
• Progressive weakness or numbness on one side of the body
• Problems with vision or speech, including double vision, loss of part of the visual field or difficulty finding words

Notice what unites this list: the symptoms tend to be persistent, progressive or new for the person. A headache that has behaved the same way for 15 years is telling a different story from one that appeared last month and gets worse every week.

Perspective is essential. Headache is one of the most common reasons people visit a doctor, and the overwhelming majority are tension-type headaches or migraines. MedlinePlus and Mayo Clinic both stress that brain tumor symptoms depend on the tumor’s size, location and growth rate, which is why they can mimic dozens of far more common conditions.

The signal that clinicians take most seriously is a cluster: for example, new headaches together with a seizure or a changed personality, or morning headaches with vomiting and blurred vision. Several new neurological symptoms arriving together, or one that keeps advancing, is the pattern that earns a scan. A single symptom, on its own, most often does not point to a tumor.

What symptoms does a meningioma cause?

Because a meningioma presses on the brain from outside rather than growing through it, its symptoms map neatly onto its address. Mayo Clinic’s list reads like a tour of the skull’s neighborhoods.

A meningioma over the top of the brain, near the motor strip, can cause gradual weakness or clumsiness in an arm or leg on the opposite side, or seizures. One near the olfactory groove behind the nose may quietly erase the sense of smell, something people rarely notice until a spouse mentions the burned toast. Tumors around the optic nerves or the pituitary region produce blurred vision, double vision or a shrinking field of view. Those near the hearing nerve can bring one-sided hearing loss or ringing. Tumors on the frontal lobes may change personality, motivation or memory in ways that are easy to misattribute to stress or aging. Headaches, when present, are often dull and worse on waking.

The timeline is the giveaway. Meningioma symptoms typically evolve over months or years, so slowly that people adjust without realizing it. Someone might switch to the other ear for phone calls long before wondering why. Cleveland Clinic points out that many meningiomas cause no symptoms at all and are found by chance, a scenario now so common that it has its own informal name among clinicians: the incidental meningioma.

Symptoms rarely settle the question of tumor type on their own. What they do is tell the doctor where to look and how urgently, and that is why describing when a symptom began and how it has changed is more useful than any single detail.

How are brain tumors and meningiomas diagnosed?

Diagnosis begins with a conversation and a neurological examination. The doctor checks strength, sensation, reflexes, coordination, eye movements, visual fields and the way you walk, looking for asymmetries that point toward a particular region of the brain. Many people are surprised that the first step involves a penlight and a reflex hammer rather than a machine.

Imaging follows when the story warrants it. MRI is the preferred test for suspected brain tumors because it shows soft tissue in fine detail and distinguishes tumor from swelling. A contrast agent given through a vein makes most tumors light up, and meningiomas characteristically enhance brightly and evenly, often with a visible attachment to the dura. CT is faster and widely available in emergency settings; it detects bleeding, calcification and larger masses well, and sometimes it is the scan on which a meningioma is first glimpsed by accident.

For many meningiomas, the appearance on MRI is distinctive enough that specialists are confident in the diagnosis without tissue. A firm answer on grade, however, requires a sample. That tissue usually comes from surgery to remove the tumor rather than a separate biopsy, and a pathologist examines it to confirm the type and assign the grade described earlier. For tumors that are simply monitored, no tissue is taken and the working diagnosis rests on imaging.

Other tests appear in specific situations: blood tests for pituitary hormones when a tumor sits near the pituitary gland, vision or hearing assessments when those nerves are involved, and occasionally a body scan to check whether a brain lesion could be a metastasis from elsewhere.

What happens after a meningioma is found?

The first question most people ask is whether something has to be done right away. Often the honest answer is no. For a small meningioma causing no symptoms, especially in an older adult, monitoring with periodic MRI is a standard approach recommended by mainstream sources including Mayo Clinic and Cleveland Clinic. The scans check whether the tumor is growing and how fast; many change little over years. How often to re-scan is an active area of research, and intervals are set by the treating team based on the tumor’s size, location and behavior rather than a fixed calendar.

Surgery is the main treatment when a meningioma is growing, causing symptoms or sitting where future growth would threaten important structures. The aim is to remove the tumor along with its attachment to the dura, and for grade 1 tumors that are removed completely, recurrence is uncommon. Whether complete removal is safe depends on location: a tumor under the top of the skull is far more accessible than one wrapped around arteries and nerves at the skull base, where surgeons may deliberately leave a portion behind rather than risk lasting damage.

Radiation therapy plays a role when surgery cannot remove everything, when a tumor returns, when the grade is higher, or when a person is not well enough for an operation. Highly focused techniques deliver radiation to the tumor while sparing surrounding tissue, and they are sometimes used as the primary treatment for small tumors in difficult positions.

Each option carries risks, from infection and bleeding after surgery to fatigue and swelling after radiation, and each is weighed against the alternative of continued observation. The decision belongs to the person and their treating team, informed by the tumor’s grade, position and pace.

What is the survival rate for brain tumors, and are they curable?

People search this question more than almost any other, and the single number that appears most often deserves careful handling. SEER reports that about 33 percent of people diagnosed with malignant brain or other nervous system cancer in the United States are alive five years later, relative to the general population. That figure is real, and it is also nearly useless for an individual, because it blends fast-growing grade 4 gliomas with slower cancers and averages across every age.

The figure excludes non-cancerous tumors entirely. Meningiomas, the most common brain tumor, do not appear in it at all. For grade 1 meningiomas that are fully removed, mainstream sources describe recurrence as uncommon and long-term outlook as favorable; for atypical and anaplastic meningiomas, the chance of regrowth rises and follow-up is closer. Anyone quoting a survival percentage for meningioma should be asked which grade, which location and which registry it came from.

Is a brain tumor 100 percent curable? No tumor of any kind can be promised at that level, and a clinician who offers a guarantee is offering something the evidence cannot support. What can be said honestly is that outcomes span an enormous range. Some low-grade tumors are removed once and never return. Some are controlled for decades with monitoring or radiation. Some high-grade cancers remain very hard to treat despite real progress in surgery, imaging and radiation techniques.

The most useful conversation about prognosis happens with the treating team, once the tumor’s type, grade, size and position are known. Those four facts predict far more than any average ever could.

When to see a doctor about possible brain tumor symptoms

Most headaches, dizzy spells and forgotten names have ordinary explanations, and reading this article is not a reason to book an MRI. Certain patterns, though, should be checked without waiting to see whether they pass.

Make an appointment promptly if you have headaches that are new for you and have steadily worsened over weeks, especially if they are worse on waking, wake you at night, or come with nausea and vomiting. The same applies to gradual weakness or numbness on one side of the body, a change in vision or hearing in one eye or ear, difficulty finding words, a fading sense of smell, or personality and memory changes that family members have noticed. Symptoms that keep progressing, or several that appear together, matter more than any one alone.

Call emergency services or go to an emergency department for red-flag signs: a first-ever seizure; a sudden, severe headache unlike any before; sudden weakness, numbness or drooping on one side of the face or body; sudden confusion, trouble speaking or loss of vision; or a headache accompanied by fever and a stiff neck. Several of these overlap with stroke and infection, which are far more common than tumors and equally time-sensitive.

If you already know you have a meningioma under observation, contact your team if any new symptom appears between scheduled scans rather than waiting for the next appointment. Slow-growing tumors do occasionally speed up, and a change in symptoms is the earliest signal.

A clinician who examines you, hears the timeline and orders imaging when warranted can settle in an afternoon what a search engine cannot settle in a month.

Frequently asked questions

What are the odds you have a brain tumor?

Low. The lifetime risk of a malignant brain or nervous system cancer in the United States is about 0.6 percent, according to SEER registry data, and new cases run at roughly 6 per 100,000 people per year. Non-cancerous tumors such as meningioma are found more often, many of them by chance on scans. A headache alone, without other neurological symptoms, is very rarely caused by a tumor.

What are 6 warning signs of a brain tumor?

The NHS lists headaches that are new or worsening, seizures, persistent nausea or vomiting with drowsiness, mental or behavioral changes, progressive weakness on one side of the body, and problems with vision or speech. Symptoms that are new for you, keep progressing, or arrive together are the ones that warrant a medical assessment. Each of these can also have far more common causes.

What is the survival rate for brain tumors?

SEER reports that about 33 percent of people diagnosed with malignant brain or other nervous system cancer are alive five years later. That average excludes non-cancerous tumors and blends very different cancers, so it says little about any individual. Outlook depends on tumor type, grade, location, age and general health, and the treating team can give a far more specific picture once those are known.

Is a brain tumor 100% curable?

No tumor can be promised a 100 percent cure, and no reputable clinician will offer one. Some low-grade tumors, including many grade 1 meningiomas, are removed completely and do not return. Others are controlled for years with monitoring or radiation. High-grade cancers remain difficult to treat. Honest prognosis comes from the specific diagnosis, not from a general figure.

Is a meningioma a brain tumor or cancer?

A meningioma is a brain tumor but usually not a cancer. It grows from the membranes covering the brain, and Johns Hopkins notes that about 80 to 90 percent are grade 1, meaning slow growing and non-cancerous. A minority are grade 2 or 3, which behave more aggressively. Even a benign meningioma can cause problems if it presses on an important area.

How common is a meningioma?

Meningioma is the most common primary brain tumor, making up about 30 percent of all brain tumors according to Johns Hopkins Medicine. It becomes more frequent with age, is rare in children, and affects women roughly twice as often as men. Many are found incidentally on scans done for unrelated reasons, and studies suggest some people carry small meningiomas without ever knowing.

Do meningiomas need to be removed?

Not always. Small meningiomas causing no symptoms are often monitored with periodic MRI scans, and many change little over years. Surgery is considered when a tumor is growing, causing symptoms, or positioned where growth would threaten important structures. Radiation therapy is an option when surgery is incomplete or unsuitable. The decision rests with the person and their treating team.

What causes a meningioma?

In most cases no cause is found. Established risk factors include earlier radiation treatment to the head and the inherited condition neurofibromatosis type 2. Female hormones appear to play a role, since meningiomas are more common in women and some carry progesterone receptors, though this is not fully understood. Cell phones have not been consistently linked to meningioma in mainstream research.

Can a brain tumor be mistaken for something else?

Yes, and the reverse happens far more often. Headaches, dizziness, memory lapses and mood changes are usually caused by migraine, tension headache, stress, sleep problems, medication effects or inner ear conditions. Brain tumor symptoms tend to be persistent and progressive, or to cluster together. A neurological examination followed by MRI when warranted distinguishes them reliably.

Are brain tumors more common in older people?

Yes. SEER data show the median age at diagnosis for malignant brain and nervous system cancer is 61, and meningiomas also become more frequent after 40. Children are an exception in a different sense: brain tumors are among the most common solid tumors of childhood even though they remain rare overall. Tumors can occur at any age.

References

• Brain tumours (NHS)
• Meningioma (Cleveland Clinic)
• Brain Tumors (MedlinePlus)

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.